G Medical Innovations announces receiving notice of patent

G Medical Innovations announces receiving notice of patent

Rehovot, Israel, Jan. 30, 2023 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical Innovations”) today......

Nogin Announces Jonathan Huberman as Chairman and Chief

Nogin Announces Jonathan Huberman as Chairman and Chief

TUSTIN, Calif., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Nogin (“Nogin” or the “Company”), a leading provider of innovative Commerce-as-a-Service (CaaS)......

Achieve Life Sciences Announces Granting of New Hire

Achieve Life Sciences Announces Granting of New Hire

SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical......

BankFinancial Corporation Reports Financial Results for

BankFinancial Corporation Reports Financial Results for

BURR RIDGE, Ill., Jan. 27, 2023 (GLOBE NEWSWIRE) -- BankFinancial Corporation (Nasdaq – BFIN) (the “Company”) announced today that the Company recorded......

Westwood One to Broadcast NFL Conference Championship

Westwood One to Broadcast NFL Conference Championship

Doubleheader Coverage of NFC and AFC Championship Games airs Sunday, January 29 beginning at 2 p.m. ET......

Capital Product Partners L.P. Schedules Fourth Quarter 2022

Capital Product Partners L.P. Schedules Fourth Quarter 2022

ATHENS, Greece, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Capital Product Partners L.P. (NASDAQ: CPLP) today announced that before the NASDAQ market opens on......

Visteon to Announce Fourth Quarter and Full-Year 2022

Visteon to Announce Fourth Quarter and Full-Year 2022

VAN BUREN TOWNSHIP, Mich., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry,......

Duolingo to Announce Fourth Quarter and Full Year 2022

Duolingo to Announce Fourth Quarter and Full Year 2022

PITTSBURGH, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile learning platform, will announce its results for......

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief

Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief

Rob Brown to continue serving as a member of the Board of Directors and as a special advisor to the Company......

Salarius Pharmaceuticals Presents SP-3164 Preclinical Data

Salarius Pharmaceuticals Presents SP-3164 Preclinical Data

Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s lymphomas, and significantly better......

  • 1
  • ...
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • menu
    menu